As of June 2022 Acorda Therapeutics has a market cap of $0.01 Billion. This makes Acorda Therapeutics the world's 6234th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.01 B | -42.42% |
2021 | $0.02 B | -31.78% |
2020 | $0.03 B | -59.67% |
2019 | $0.09 B | -86.83% |
2018 | $0.73 B | -26.32% |
2017 | $1.00 B | 15.66% |
2016 | $0.86 B | -52.86% |
2015 | $1.83 B | 7.46% |
2014 | $1.71 B | 43.35% |
2013 | $1.19 B | 20.68% |
2012 | $0.98 B | 4.61% |
2011 | $0.94 B | -10.51% |
2010 | $1.05 B | 10.55% |
2009 | $0.95 B | 23.58% |
2008 | $0.77 B | 23.27% |
2007 | $0.62 B | 67.45% |
2006 | $0.37 B |
On Jun 23rd, 2022 the market cap of Acorda Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT | $6.58 B | 51,667.17% | ๐บ๐ธ USA |
![]() Repligen
RGEN | $9.19 B | 72,222.28% | ๐บ๐ธ USA |
![]() Affimed
AFMD | $0.40 B | 3,082.68% | ๐ฉ๐ช Germany |
![]() BioMarin Pharmaceutical BMRN | $16.06 B | 126,268.23% | ๐บ๐ธ USA |